MedTrace Logo

Effect of Dexmedetomidine As Adjuvant to Ropivacaine for Brachial Plexus Block

NCT05767827 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2024-09-04

No results posted yet for this study

Summary

Brachial plexus block is used for upper limb surgery. Local anesthesia alone for brachial plexus block provides good operative conditions, but have short duration of postoperative analgesia. Hence, various adjuvants to local anaesthetic agents to prolong the duration of peripheral nerve, analgesia. However, results are either inconclusive or associated with side effects. The purpose of this study is to determine whether dexmedetomidine as an adjuvant to ropivacaine in brachial plexus block improve quality of block in terms of duration of post operative analgesia.

Conditions

  • Local Anesthesia Adjuvants
  • Upper Extremity Fracture
  • Brachial Plexus Block

Interventions

DRUG

ropivacaine, lidocaine with adrenaline

Group R includes 0.35% ropivacaine 20ml, 1.5 % lidocaine with adrenaline 10ml

DRUG

Dexmedetomidine, ropivacaine, lidocaine with adrenaline

Dexmedetomidine 1mcg/kg and 0.35% ropivacaine with normal saline (20ml), 1.5% lidocaine with adrenaline (10ml) in group RD

Sponsors & Collaborators

  • Nepal Medical College and Teaching Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
20 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-02-01
Primary Completion
2023-07-30
Completion
2024-08-30

Countries

  • Nepal

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05767827 on ClinicalTrials.gov